Unlock stock picks and a broker-level newsfeed that powers Wall Street.
4.4300
-0.2100
(-4.53%)
At close: April 1 at 4:00:02 PM EDT
4.9900
+0.56
+(12.64%)
Pre-Market: 4:18:34 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 8 | 8 |
| Avg. Estimate | -0.32 | -0.34 | -1.54 | -1.63 |
| Low Estimate | -0.5 | -0.54 | -2.31 | -2.34 |
| High Estimate | -0.13 | -0.17 | -0.69 | -0.67 |
| Year Ago EPS | -0.53 | -0.43 | -0.98 | -1.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 8 |
| Avg. Estimate | 13.57M | 13.57M | 53.54M | 35.57M |
| Low Estimate | -- | -- | 13M | -- |
| High Estimate | 32M | 32M | 114.51M | 171.76M |
| Year Ago Sales | 1.06M | 4.7M | 75.62M | 53.54M |
| Sales Growth (year/est) | 1,175.06% | 188.96% | -29.20% | -33.57% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.58 | -0.54 | -0.47 | 0.03 |
| EPS Actual | -0.53 | -0.43 | -0.29 | 0.27 |
| Difference | 0.05 | 0.11 | 0.18 | 0.24 |
| Surprise % | 8.15% | 20.49% | 38.42% | 902.60% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.32 | -0.34 | -1.54 | -1.63 |
| 7 Days Ago | -0.41 | -0.41 | -1.43 | -1.63 |
| 30 Days Ago | -0.41 | -0.41 | -1.6 | -1.83 |
| 60 Days Ago | -0.41 | -0.41 | -1.6 | -1.83 |
| 90 Days Ago | -0.41 | -0.41 | -1.6 | -1.83 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 3 | 3 | 3 |
| Up Last 30 Days | 3 | 3 | 3 | 3 |
| Down Last 7 Days | 1 | 1 | 2 | 1 |
| Down Last 30 Days | 1 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GLUE | 39.23% | 20.03% | -56.85% | -6.07% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/21/2025 |
| Maintains | Wedbush: Outperform to Outperform | 3/21/2025 |
| Initiated | LifeSci Capital: Outperform | 3/12/2025 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 12/19/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 9/12/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 8/12/2024 |
Related Tickers
TYRA Tyra Biosciences, Inc.
8.72
-6.24%
TCRX TScan Therapeutics, Inc.
1.2700
-7.97%
KYMR Kymera Therapeutics, Inc.
25.24
-7.80%
DNTH Dianthus Therapeutics, Inc.
16.83
-7.22%
RLYB Rallybio Corporation
0.6100
-6.80%
IPSC Century Therapeutics, Inc.
0.4518
-5.08%
CGEM Cullinan Therapeutics, Inc.
7.50
-0.92%
RVMD Revolution Medicines, Inc.
33.62
-4.92%
RLAY Relay Therapeutics, Inc.
2.4700
-5.73%
NRIX Nurix Therapeutics, Inc.
10.47
-11.87%